Stock SURG SURGEPAYS, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Consensus SurgePays, Inc.

Equities

SURG

US86882L2043

Market Closed - Nasdaq
Other stock markets
 04:00:00 2024-04-18 pm EDT 		5-day change 1st Jan Change
3.73 USD -0.80% Intraday chart for SurgePays, Inc. -9.47% -42.17%
Apr. 17 Certain Common Stock of SurgePays, Inc. are subject to a Lock-Up Agreement Ending on 17-APR-2024. CI
Apr. 01 Ascendiant Capital Adjusts SurgePays' Price Target to $10 From $11.50, Keeps Buy Rating MT

Evolution of the average Target Price on SurgePays, Inc.

Price target over the last 5 years

History of analyst recommendation changes

c9dd5900201bb4453339.cxq_5dSoMpcXjZ0gAwJKJR-OO7RQljXPCIJXnh4C65A.IGzqkuXlH6dAzN5PdGYvdmj6cuIE_k2nR9A7zWt0iqBAV_q8l9hV3GTe7g~6f4988fd1873ba54387f35de422bda72

Analyst Recommendations on SurgePays, Inc.

Ascendiant Capital Adjusts SurgePays' Price Target to $10 From $11.50, Keeps Buy Rating MT
Maxim Downgrades SurgePays to Hold From Buy MT
Maxim Raises SurgePays Price Target to $10 From $8, Maintains Buy Rating MT
Maxim Adjusts SurgePays' Price Target to $8 From $6, Reiterates Buy Rating MT
Maxim Starts SurgePays at Buy with $6 Price Target MT
Ascendiant Capital Starts SurgePays at Buy With $7 Price Target MT
More recommendations

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
2
Last Close Price
3.73 USD
Average target price
10 USD
Spread / Average Target
+168.10%
High Price Target
10 USD
Spread / Highest target
+168.10%
Low Price Target
10 USD
Spread / Lowest Target
+168.10%

Consensus detail

Consensus revision (last 18 months)

Analysts covering SurgePays, Inc.

Ascendiant Capital
Maxim

Ratings for SurgePays, Inc.

Trading Rating
Investor Rating
ESG Refinitiv
More Ratings

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar
  1. Stock Market
  2. Equities
  3. SURG Stock
  4. Consensus SurgePays, Inc.